Other and unspecified disorders of sclera

H7_SCLERANAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H15.8, H15.9 Hospital discharge: ICD-9 — 3791A Cause of death: ICD-10 — H15.8, H15.9 Cause of death: ICD-9 — 3791A 2 out of 7 registries used, show all original rules.	57
4. Check minimum number of events None	57
5. Include endpoints None	57
6. Filter based on genotype QC (FinnGen only)	51

Control definitions (FinnGen only)

Control exclude: H7_SCLERACORNEA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4

NAME	H7_SCLERANAS
CONTROL_EXCLUDE	H7_SCLERACORNEA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H15[8-9]
HD_ICD_9	3791A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H15[8-9]
COD_ICD_9	3791A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified disorders of sclera based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	362	196	165
Only index persons	313	174	139
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	51.04	55.01	46.16
Only index persons	50.67	55.27	44.91

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	51	36	15
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	60.83	60.84	60.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
53: Matched controls
530

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H15.9

ICD-10 Finland

Disorder of sclera, unspecified

+∞

34.1

H15.8

ICD-10 Finland

Other disorders of sclera

457.2

27.4

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

+∞

7.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

4.7

6.8

165

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

132

3.38

4.54

2.1

2.5

162.00

212.19

u/l

0.23

124

(42870588) Differential panel, method unspecified - Blood

150

2.84

3.40

6.6

7.2

—

(3008898) HLA-B27 [Presence]

6.07

3.33

1.0

—

(3006315) Basophils [#/volume] in Blood

246

2.67

2.72

6.9

6.7

0.05

0.04

e9/l

1.22

219

(3001604) Monocytes [#/volume] in Blood

246

2.67

2.72

6.9

6.6

0.57

0.55

e9/l

0.24

219

(3019198) Lymphocytes [#/volume] in Blood

250

2.59

2.57

6.9

6.8

2.06

2.19

e9/l

0.13

228

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.62

2.54

1.6

1.3

10.19

34.69

iu/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

5.48

2.47

1.8

—

(3013115) Eosinophils [#/volume] in Blood

257

2.46

2.31

7.1

6.7

0.22

0.19

e9/l

0.57

233

(3037522) Nuclear Ab [Titer] in Serum

2.47

2.05

1.5

1.3

160.00

714.29

titre

—

(3037467) Urinalysis macro (dipstick) panel - Urine

327

2.37

1.76

5.3

4.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.82

1.65

1.0

1.1

—

(40768443) Skin Pathology biopsy report

3.25

1.63

1.0

1.2

—

(3018418) pH of Serum or Plasma

149

1.96

1.52

3.1

4.6

7.40

0.05

116

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.94

1.48

5.0

9.0

25.33

24.64

mmol/l

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.95

1.31

2.0

3.7

24.20

24.95

mmol/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.95

1.31

1.0

1.1

—

(3022145) Colonoscopy Study observation

2.43

1.31

1.8

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

346

2.03

1.24

6.9

4.7

11.43

11.24

mm/h

0.04

313

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.79

1.24

1.2

1.20

g/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.79

1.24

1.2

0.23

0.26

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.21

0.0

1.0

—

(40768797) Stomach Pathology biopsy report

2.06

1.21

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.65

1.18

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

188

1.75

1.15

2.3

2.0

106.70

95.07

pmol/l

1.00

(3031040) Bacteria [#/volume] in Urine by Automated count

308

1.83

1.12

3.9

4.4

—

29.50

—

(3000991) Gas panel - Venous blood

2.29

1.10

5.4

12.9

—

(40758558) Short blood count panel - Blood

164

1.71

1.05

6.6

6.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

113

1.74

0.98

1.6

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.97

0.95

1.9

1.6

—

(3021589) Normoblasts [#/volume] in Blood

217

1.62

0.90

8.9

12.1

0.00

e9/l

-0.00

178

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.89

0.87

1.8

1.4

—

(3032080) INR in Blood by Coagulation assay

200

1.59

0.84

13.5

8.9

1.27

1.14

inr

0.52

160

(3007853) Bacteria identified in Skin by Aerobe culture

1.91

0.76

1.9

1.5

—

(40761535) Cells panel - Urine sediment

2.02

0.72

3.2

3.1

—

(3042936) Bacteria identified in Isolate by Culture

1.72

0.72

2.5

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.69

0.68

2.1

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1.80

0.65

1.8

3.5

14.46

48.23

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

121

0.60

0.64

1.6

—

(3020891) Body temperature

0.00

0.62

0.0

4.5

—

36.94

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.62

0.0

3.2

—

45.26

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.62

0.0

1.3

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.62

0.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.62

0.0

2.8

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.61

0.0

1.1

—

(3027008) Opiates [Presence] in Urine

0.00

0.61

0.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.57

0.60

1.3

1.7

—

(3015736) pH of Urine

194

1.43

0.56

3.9

3.5

6.25

6.22

0.04

110

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.59

0.56

2.5

2.9

1.00

5.02

e6/l

—

(3003694) ABO and Rh group [Type] in Blood

151

0.66

0.52

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

226

1.40

0.51

2.4

2.9

—

estimate

—

(1761868) Lipid panel - Serum or Plasma

182

0.69

0.51

2.2

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

307

1.41

0.50

3.8

3.2

36.14

47.02

u/l

0.98

288

(3044640) Blood type and Crossmatch panel - Blood

150

1.42

0.50

1.8

2.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

0.61

0.47

3.7

2.8

2.45

2.46

mmol/l

—

(3000494) Fungus identified in Specimen by Culture

1.45

0.44

1.9

1.5

—

(1002224) Polysomnography panel

1.62

0.43

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.57

0.42

1.4

2.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

0.42

0.0

5.1

—

8.48

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

0.00

0.42

0.0

2.8

—

24.53

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.42

0.0

3.5

—

25.55

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.41

0.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.40

0.0

1.1

—

(3016879) Cocaine [Presence] in Urine

0.00

0.40

0.0

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

441

1.58

0.36

14.5

14.8

82.41

83.55

ml/min/173m2

0.15

403

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.39

0.33

2.9

2.8

0.22

1.15

e6/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.31

0.31

1.6

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.34

0.30

1.5

2.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.31

0.25

2.2

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.39

0.24

1.0

1.3

—

(3000492) Spirometry study

1.35

0.24

2.4

1.7

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.31

0.23

2.0

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.21

0.22

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

9.02

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.7

—

(1616796) Gas panel - Central venous blood

0.00

0.21

0.0

5.0

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3010421) pH of Blood

0.00

0.21

0.0

4.4

—

7.40

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.21

0.0

3.9

—

90.42

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.00

0.21

0.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.2

—

21.23

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.20

0.0

4.1

—

3.85

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

100

1.26

0.20

1.6

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

297

1.20

0.19

3.5

3.2

—

(3013512) EKG study

149

1.21

0.19

2.8

3.5

—

(3023368) Bacteria identified in Blood by Culture

111

1.23

0.18

2.3

3.7

—

(3018095) Leukocytes [#/volume] in Urine

180

1.18

0.16

4.5

3.7

41.43

60.27

e6/l

0.18

120

(3000850) Epithelial cells [#/volume] in Urine

0.77

0.15

3.1

2.6

4.21

8.23

e6/l

—

(3026008) Bacteria identified in Urine by Culture

144

1.16

0.12

2.3

2.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

155

0.87

0.11

2.9

2.3

46.29

86.01

u/l

0.76

138

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

116

1.16

0.10

1.6

1.4

14.12

0.73

u/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.18

0.10

1.5

1.6

—

(4035726) Immunohistochemistry procedure

1.05

0.09

1.4

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

113

0.86

0.09

4.3

5.5

—

(3027945) Reticulocytes/Erythrocytes in Blood

1.08

0.09

2.0

4.1

1.52

1.45

—

(3030467) Casts [#/volume] in Urine by Automated count

137

1.13

0.08

3.1

2.9

0.03

0.28

e6/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.13

0.08

1.4

1.3

—

(3002256) Pathology report gross observation

1.07

0.08

1.4

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

151

0.90

0.06

3.8

3.9

30.38

12.82

mg/mmol

—

(3012516) Albumin [Mass/volume] in Urine

147

0.94

0.02

3.6

3.2

168.95

71.42

mg/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

166

0.95

0.00

2.9

3.1

2.37

mmol/l

0.06

154

(3002582) Erythrocytes [#/volume] in Urine

158

1.02

0.00

3.3

3.0

29.14

31.13

e6/l

0.03

117

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

2.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

3.0

—

3.57

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.1

—

0.42

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

3.8

—

0.94

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.3

—

19.32

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.0

—

167.57

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

1.8

—

35.50

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

3.7

—

4.91

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

3.7

—

8.64

—

(40768804) Tissue Pathology biopsy report

210

1.00

-0.00

3.8

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3026782) Osmolality of Urine

1.01

-0.00

2.3

2.6

535.50

470.30

mosm/kgh2o

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

3.50

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

6.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(4268621) Lupus anticoagulant assay

0.00

-0.00

0.0

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

1.6

—

0.40

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

30.08

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

-0.00

0.0

39.3

—

135.00

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

9.40

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.86

-0.00

2.2

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.4

—

249.60

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

-0.00

0.0

2.3

—

37.00

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.4

—

4.71

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.0

—

32.00

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

-0.00

0.0

5.4

—

16.59

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.0

—

7.40

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

-0.00

0.0

1.6

—

10.00

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

5.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.6

—

7.83

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

0.94

-0.00

3.0

6.1

107.60

103.66

mmol/l

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.0

—

349.94

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.4

—

10.26

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_SCLERANAS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_SCLERANAS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H7_SCLERANAS – Other and unspecified disorders of sclera

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified disorders of sclera

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints